Organ Transplant Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - By Offering (Kits and Assays, Consumables, and Services), By Application (Donor Testing (Pre-transplantation testing (Histocompatibility Testing, Blood Profiling Testing, and Other Testing), Post-transplantation testing (Post-Infection Testing, Risk of Disorder Testing, and Other Testi
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationOrgan Transplant Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - By Offering (Kits and Assays, Consumables, and Services), By Application (Donor Testing (Pre-transplantation testing (Histocompatibility Testing, Blood Profiling Testing, and Other Testing), Post-transplantation testing (Post-Infection Testing, Risk of Disorder Testing, and Other Testi
Organ transplant diagnostics involves a range of medical tests and procedures that are used to assess the compatibility between a potential organ donor and recipient. It also evaluates the condition of the organ before and after the transplantation. Various kinds of test that are involved in diagnosis of organ transplantation include blood tests, cross-matching, imaging tests, biopsy, echocardiogram, pulmonary function tests, and endoscopy. According to the data from the Global Observatory on Donation and Transplantation of 2020, the United States has been ranked as the highest position accounting for almost 40,000 transplantations in a year, followed by China, Brazil, Spain, and India. Among various organ transplantations, heart transplant recipients may need to undergo more diagnostic tests than other transplant recipients because of the complexity of the heart and the potential for complications. Some of the diagnostic tests that may be required for heart transplant recipients include echocardiograms, electrocardiograms, and cardiac catheterization. The growing prevalence of various chronic diseases such as cardiovascular diseases, chronic respiratory diseases, musculoskeletal diseases, neurological disorders, and kidney diseases is expected to register a lucrative growth of the global organ transplant diagnostics market during the forecast period. Many diagnostic tests are required for carrying out the transplantations of vital organs in the body which is increasing the demand for diagnostics in the market. Furthermore, growing geriatric population across the world and the emergence of various diseases such as arthritis, dementia, osteoporosis, and chronic obstructive pulmonary disease (COPD) are associated with people in their elder age. Such factors are expected to propel the growth of the global organ transplant diagnostics market in the coming years.
Rising Prevalence of Chronic Diseases
. According to Global Observatory on Donation and Transplantation (GODT) reported that globally around 139,347 organ transplantations were performed in 2019, followed by 144,302 organ transplantations performed across the world in 2021 with an increase of 11.3% from 2020. As per the report published by Health Resources & Services Administration (HSRA), it has been concluded that around 25,499 kidney transplantations were performed in 2022, followed by 9,528 liver transplantations, 4,111 heart transplantations, and 2,692 lung transplantations across the world.
Increase in Geriatric Population
According to data from the Organ Procurement and Transplantation Network (OPTN), in 2020, there were a total of 39,035 kidney transplants performed in the United States. Of these, 5,819 (14.9%) were performed in recipients who were 65 years of age or older.
Recent Developments
- In January 2022, Hoffmann-LA Roche Ltd. unveiled Cobas Infinity edge, a cloud-based point-of-care platform that is available everywhere. Practitioners in the healthcare industry can manage patient data due to advanced technology. This has aided the business in diversifying its product offering.
- In January 2019, Core Diagnostics launched its division for advanced diagnostic centers in nephrology called ‘nephroCORE’. These services will ensure the best clinical intervention to improve outcomes in several chronic and generic kidney diseases, including kidney transplants.
- In August 2019, Care Dx (United States) acquired XynManagement (United States) to simplify transplant quality tracking and waitlist management.
- In February 2019, Care Dx (United States) launched the Allosure for lung transplants.
- In March 2022, Immucor, Inc., a company focused on transfusion and transplantation diagnostics, announced two additions to its transplant diagnostics portfolio, demonstrating its ongoing commitment to new advancements in the field of histocompatibility.
- In March 2022, Biocartis and Ophiomics entered into a collaboration to focus on the commercialization of HepatoPredict, a prognostic gene expression signature test to identify which patients will benefit from liver transplantation.
- In August 2022, QIAGEN announced the publication in the Journal of Molecular Pathology of an externally facilitated clinical NGS interpretation validation study, demonstrating that its clinical decision support software, QIAGEN Clinical Insight Interpret One (QCI Interpret One), achieved a higher level of concordance with a panel of experts than human reviewers achieved among each other. The study commissioned by QDI and carried out independently by Genomics Quality Assessment (GenQA) investigated the classification of variants reported from oncology patient samples. This has helped the company to validate its research.
- In April 2023, bioMérieux S.A. and Oxford Nanopore entered into a strategic partnership agreement to develop innovative infectious disease diagnostics, which would also lead to the development of infectious disease tests used during transplantation.
- In April 2023, CareDx and Miromatrix announced an exclusive partnership to advance research using bioengineered organs for human transplantation.
- In November 2022, Bio-Rad Laboratories and NuProbe USA signed a licensing agreement for digital PCR assay development. The technology would advance Bio-Rad’s portfolio.
- In October 2022, Eurobio Scientific finalized the purchase of a 100% stake in Genome Diagnostics BV (GenDx) in a deal valued at $132.3 million.
- In September 2022, BioMAdvanced Diagnostics announced fundraising of $1.3 million. The fundraising would allow BioMAdvanced Diagnostics to finalize the design of its first products and to start two clinical studies, one on the rejection of kidney transplants and the other on the lung.
- In September 2022, GenDx announced that it had signed a non-exclusive service agreement with Oxford Nanopore Technologies (Oxford Nanopore) to bring its new NGS-Turbo product to the transplant market for high-resolution HLA typing.
Market Segmentation
The global organ transplant diagnostics market is segmented based on offering, application, transplant type, technology, end user, and region. In terms of offering, the global organ transplant diagnostics market is categorized into kits and assays, consumables, and services. Based on application, the global organ transplant diagnostics market is fragmented into donor testing (pre-transplantation testing (histocompatibility testing, blood profiling testing, and other testing), post-transplantation testing (post-infection testing, risk of disorder testing, and other testing)), recipient testing (pre-transplantation testing (histocompatibility testing, blood profiling testing, and other testing), post-transplantation testing (post-infection testing, risk of disorder testing, and other testing). Based on transplant type, the market is segmented into solid organ transplant (kidney, liver, lung, pancreas, other organs transplant), and stem cell transplant. Based on technology, the market is fragmented into molecular technologies (PCR, sanger sequencing, next-generation sequencing (NGS), and other molecular technologies), non-molecular technologies (serology, flow cytometry), and other technologies. Based on end user, the market is categorized into hospitals and transplant centers, academic and research institutions, reference laboratories, and other end users.
Market Players
Abbott Laboratories, bioMérieux S.A., Bio-Rad Laboratories, Inc., Eurobio Scientific (Genome Diagnostics B.V.), F. Hoffmann-La Roche Ltd., Omixon Inc., Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, CareDx, Inc., and Core Diagnostics Private Limited are some of the key players in the global organ transplant diagnostics market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, Volume in tons and CAGR for 2018-2022 and 2023-2028 |
| Report coverage | Revenue forecast, Volume forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | · Offering · Application · Transplant Type · Technology · End User |
| Regional scope | North America; Asia Pacific; Europe; South America; Middle East & Africa |
| Country scope | United States; Canada; Mexico; China; India; Japan; Australia; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; |
| Key companies profiled | Abbott Laboratories, bioMérieux S.A., Bio-Rad Laboratories, Inc., Eurobio Scientific (Genome Diagnostics B.V.), F. Hoffmann-La Roche Ltd., Omixon Inc., Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, CareDx, Inc., Core Diagnostics Private Limited |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy